Abstract:Some of the most metabolically diverse species of bacteria (e.g., Actinobacteria) have higher GC content in their DNA, differ substantially in codon usage, and have distinct protein folding environments compared to tractable expression hosts like Escherichia coli . Consequentially, expressing biosynthetic gene clusters (BGCs) from these bacteria in E. coli often results in a myriad of unpredictable issues with regard to protein expression and folding, delaying the biochemical characterization of new natural products. Current strategies to achieve soluble, active expression of these enzymes in tractable hosts can be a lengthy trial-and-error process. Cell-free expression (CFE) has emerged as a valuable expression platform as a testbed for rapid prototyping expression parameters. Here, we use a type III polyketide synthase from Streptomyces griseus , RppA, which catalyzes the formation of the red pigment flaviolin, as a reporter to investigate BGC refactoring techniques. We applied a library of constructs with different combinations of promoters and rppA coding sequences to investigate the synergies between promoter and codon usage. Subsequently, we assess the utility of cell-free systems for prototyping these refactoring tactics prior to their implementation in cells. Overall, codon harmonization improves natural product synthesis more than traditional codon optimization across cell-free and cellular environments. More importantly, the choice of coding sequences and promoters impact protein expression synergistically, which should be considered for future efforts to use CFE for high-yield protein expression. The promoter strategy when applied to RppA was not completely correlated with that observed with GFP, indicating that different promoter strategies should be applied for different proteins. In vivo experiments suggest that there is correlation, but not complete alignment between expressing in cell free and in vivo. Refactoring promoters and/or coding sequences via CFE can be a valuable strategy to rapidly screen for catalytically functional production of enzymes from BCGs, which advances CFE as a tool for natural product research.

Application of a Cell-Free Synthetic Biology Platform for the Reconstitution of Teleocidin B and UK-2A Precursor Biosynthetic Pathways

Plant-Derived Cell-Free Biofactories for the Production of Secondary Metabolites

Establishing modular cell‐free expression system for the biosynthesis of bicyclomycin from a chemically synthesized cyclodipeptide

Cell-free expression of NO synthase and P450 enzyme for the biosynthesis of an unnatural amino acid L-4-nitrotryptophan

Enzymatic reactions in teleocidin B biosynthesis

Efficient production of clerodane and ent-kaurane diterpenes through truncated artificial pathways in Escherichia coli

A modular and synthetic biosynthesis platform for de novo production of diverse halogenated tryptophan-derived molecules

Simple and rapid direct cloning and heterologous expression of natural product biosynthetic gene cluster in Bacillus subtilis via Red/ET recombineering

Profiling expression strategies for a type III polyketide synthase in a lysate-based, cell-free system

Cell-Free Synthesis of Natural Compounds from Genomic DNA of Biosynthetic Gene Clusters

Engineering a Biosynthetic Pathway for the Production of (+)-Brevianamides A and B in Escherichia coli

Reconstitution of the FK228 biosynthetic pathway reveals cross talk between modular polyketide synthases and fatty acid synthase

Construction of ajmalicine and sanguinarine de novo biosynthetic pathways using stable integration sites in yeast

Reshaping the 2‐pyrone Synthase Active Site for Chemoselective Biosynthesis of Polyketides

Back to the plant: overcoming roadblocks to the microbial production of pharmaceutically important plant natural products

Heterologous Biosynthesis of Type II Polyketide Products Using <i>E</i>. <i>coli</i>

Antibiotic Skeletal Diversification via Differential Enoylreductase Recruitment and Module Iteration in trans -Acyltransferase Polyketide Synthases

High-Titer Heterologous Production in E. coli of Lyngbyatoxin, a Protein Kinase C Activator from an Uncultured Marine Cyanobacterium

Integrated pathway mining and selection of an artificial CYP79-mediated bypass to improve benzylisoquinoline alkaloid biosynthesis

Tools of pathway reconstruction and production of economically relevant plant secondary metabolites in recombinant microorganisms

Biosynthetic pathway redesign in non-conventional yeast for enhanced production of cembratriene-ol